Actualités

Klaviyo, Inc. (KVYO) delivered earnings and revenue surprises of 0.00% and +2.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Allient (ALNT) delivered earnings and revenue surprises of +29.03% and +5.12%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

UWM (UWMC) delivered earnings and revenue surprises of -428.57% and +1.88%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Redwire Corporation (RDW) delivered earnings and revenue surprises of +50.00% and +11.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Fluence Energy (FLNC) delivered earnings and revenue surprises of -380.00% and -21.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Evolus (EOLS) delivered earnings and revenue surprises of +100.00% and +2.59%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Duolingo (DUOL) delivered earnings and revenue surprises of +8.20% and +0.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

IonQ (IONQ) delivered earnings and revenue surprises of -13.79% and +20.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Digi International (DGII) delivered earnings and revenue surprises of +11.94% and +4.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The headline numbers for Fluence Energy (FLNC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Record fundraising and Oaktree completion drive AI infrastructure expansion.

Pfizer (PFE) is back in focus after its second quarter 2026 update, which paired a reported net loss and sizeable non cash impairments with higher full year revenue guidance and solid non COVID product performance. See our latest analysis for Pfizer. The latest results and raised revenue guidance have lifted sentiment toward Pfizer, with the stock showing a 1 month share price return of 8.81% and a 1 year total shareholder return of 15.42%, although longer term total shareholder returns...

Japanese stocks were lower in early trade following Wednesday’s sharp gains led by artificial intelligence-related shares.

DoorDash (NASDAQ:DASH) executives said the company’s Q2 2026 performance reflected continued growth in restaurant delivery, grocery and retail, international operations and subscription adoption, while improved unit economics supported profitability and ongoing investment in technology. During the

Clover Health Investments (NASDAQ:CLOV) reported second-quarter results that showed continued Medicare Advantage membership growth alongside profitability, while raising its full-year 2026 outlook across its key financial measures. Chief Executive Officer Andrew Toy said the company views its Clove

Cirrus Logic (NASDAQ:CRUS) reported record fiscal first-quarter revenue of $460 million for the June quarter, up 2% sequentially and 13% from a year earlier, driven by higher component sales into smartphones. The company posted GAAP earnings per share of $1.47 and non-GAAP earnings per share of $1.8

Although the revenue and EPS for Transocean (RIG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The headline numbers for SYMBOTIC INC (SYM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

While the top- and bottom-line numbers for Solaris Energy Infrastructure, Inc. (SEI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for Duolingo (DUOL) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for Fastly (FSLY) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for Figma, Inc. (FIG) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

A leveraged AMD fund turned a modest stake into a small fortune over seven months, then a single earnings report wiped out nearly a quarter of those gains in hours. Here is what the 302% run actually cost its holders.

The entertainment giant crushed analyst profitability estimates for its third quarter.

Western Digital topped quarterly earnings and revenue estimates, but a cautious outlook appeared to weigh on investor sentiment, sending the stock sharply lower in after-hours trading.

For the third quarter, AppLovin guided revenue of $2.055–$2.085 billion, lower at the midpoint than Wall Street estimates of $2.08 billion.

Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Lam Research (LRCX) has drawn fresh attention after reporting quarterly and full year results on July 29, 2026, along with new guidance for the September quarter and commentary tied to AI driven semiconductor demand. See our latest analysis for Lam Research. At a share price of US$307.42, Lam Research has seen a sharp 7 day share price return of 21.82% after recent earnings and guidance, even though the 30 day share price return is down 12.22%. The 1 year total shareholder return of 222.20%...

Grab Holdings (NasdaqGS:GRAB) raised its full year 2026 revenue and earnings guidance after a strong second quarter, giving investors fresh numbers to assess the stock’s risk reward profile. See our latest analysis for Grab Holdings. The raised guidance and buyback news arrive after a mixed period for Grab Holdings, with the share price down 26.38% year to date but a 7 day share price return of 11.64% and a 1 year total shareholder return decline of 21.59%. Recent gains suggest short term...

As investors look to balance growth opportunities with defensive positioning, Acadia Pharmaceuticals, CVS Health, and Eli Lilly stand out as healthcare names combining resilient business models with strong earnings momentum.